Emergent BioSolutions (EBS) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.28 --0%
EPS Growth %: -31.3%
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
CRMT, More
EPS Growth %: -31.3%
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $192.5 million versus the consensus estimate of $199.47 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Isabella Bank added to Russell 2000 index after Nasdaq listing
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
